Hologic Affirm Prone Biopsy System: Features, Clinical Value, and Where to Buy

When a screening mammogram identifies a suspicious lesion, the next step — tissue sampling through breast biopsy — is one of the most critical touchpoints in the breast cancer care continuum. The accuracy, speed, and patient experience of that biopsy procedure depend heavily on the guidance platform used. The Hologic Affirm prone biopsy system is purpose-built for stereotactic and tomosynthesis-guided breast biopsies performed with the patient in a prone (face-down) position, and it has become the preferred platform for dedicated breast biopsy suites across the United States. This guide covers the system's features, clinical advantages, cost considerations, and how to purchase a new or refurbished Affirm system through ARRAD.

System Overview: What Is the Hologic Affirm Prone Biopsy System?

The Hologic Affirm prone biopsy system is a dedicated breast biopsy table designed exclusively for image-guided tissue sampling. Unlike upright add-on biopsy systems that attach to a standard mammography gantry, the Affirm prone table positions the patient face-down on an elevated platform with the breast suspended through an aperture in the table surface. The radiologist and technologist work beneath the table, accessing the breast for compression, targeting, and needle placement.

The system supports two primary guidance modes:

• Stereotactic guidance: Uses paired angled X-ray images to calculate the three-dimensional coordinates of a lesion for precise needle placement. This is the standard approach for targeting calcifications and other mammographically visible abnormalities.
• Tomosynthesis-guided (tomo-guided) biopsy: Uses the same 3D imaging technology as Hologic's screening tomosynthesis systems to visualize and target lesions that may be visible only on tomosynthesis views. This capability is increasingly important as more facilities adopt 3D screening and identify findings that are occult on conventional 2D images.

The Affirm prone system integrates with Hologic's Dimensions-series X-ray components, including a high-resolution digital detector, automated compression and positioning controls, and digital imaging software that provides real-time targeting verification. The system is compatible with all standard vacuum-assisted biopsy devices, including the Hologic ATEC and Eviva systems.

Clinical Advantages of Prone Positioning

The prone biopsy approach offers several well-documented clinical advantages over upright stereotactic biopsy systems, which is why the Hologic Affirm has become the standard configuration for dedicated biopsy programs:

• Reduced vasovagal reactions: Vasovagal syncope (fainting) is one of the most common complications of breast biopsy procedures. Studies published in the American Journal of Roentgenology have reported vasovagal reaction rates of 1–6% with upright biopsy positioning, compared to less than 1% with prone positioning. The prone position stabilizes blood pressure and reduces the anxiety associated with watching the procedure, resulting in a safer and calmer patient experience.
• Superior lesion access: The prone table allows the breast to fall naturally through the aperture under gravity, often providing better access to posterior and medial lesions that can be difficult to reach in an upright compression paddle. This expanded access reduces the number of cases that must be referred to MRI-guided biopsy, which is significantly more expensive and time-consuming.
• Greater patient stability: With the patient lying prone, there is minimal body movement during the targeting and sampling phases. This stability translates to more accurate needle placement and fewer post-procedure complications. Published accuracy rates for prone tomosynthesis-guided biopsy exceed 98% for lesion retrieval on first attempt.
• Improved workflow: The ergonomic design of the Affirm prone table allows the radiologist and technologist to work comfortably beneath the table without the postural strain associated with reaching around a standing patient. This results in faster procedures and reduced staff fatigue during high-volume biopsy days.

For facilities performing 3 or more image-guided breast biopsies per week, a dedicated prone system like the Affirm is a clinically superior and operationally more efficient solution than relying on an upright add-on module attached to a screening mammography unit.

Regulatory and Accreditation Considerations

Operating a breast biopsy program requires compliance with several overlapping regulatory frameworks. The Hologic Affirm prone biopsy system is designed to meet all applicable standards:

• FDA clearance: The Affirm system is FDA-cleared for stereotactic and tomosynthesis-guided breast biopsy. All imaging components meet federal performance standards for mammographic X-ray equipment under 21 CFR Part 900.
• MQSA compliance: Facilities performing mammography-guided biopsies must operate under a valid MQSA certificate. The Affirm system supports all required quality control procedures, including phantom image quality testing, compression force verification, and exposure reproducibility checks.
• ACR accreditation: While ACR accreditation for stereotactic breast biopsy is voluntary (unlike screening mammography accreditation, which is mandatory under MQSA), many facilities pursue it as a quality benchmark. The Affirm system's image quality and targeting accuracy support successful ACR stereotactic biopsy accreditation.
• State regulations: Some states have additional requirements for radiation-producing equipment, including registration, shielding verification, and annual physics surveys. ARRAD assists facilities with state-specific compliance documentation as part of the installation process.

Cost Analysis and Financial Planning

The Hologic Affirm prone biopsy system is a specialized piece of capital equipment, and pricing reflects its dedicated clinical purpose:

• New Hologic Affirm prone table: $275,000 – $400,000, depending on whether the system includes the tomosynthesis-guided biopsy option or is configured for stereotactic guidance only.
• Refurbished Hologic Affirm: $100,000 – $200,000 for a professionally refurbished system with full functional testing, OEM parts, and warranty coverage. ARRAD's refurbished inventory includes Affirm systems at various configuration levels.
• Annual service and maintenance: $20,000 – $35,000 for comprehensive coverage including preventive maintenance, emergency repair, and software support.
• Installation and site preparation: $12,000 – $30,000, covering electrical work, radiation shielding, and table installation. The Affirm system requires a dedicated procedure room with specific floor loading and clearance dimensions.
• Consumables and biopsy supplies: Vacuum-assisted biopsy needles, marker clips, and specimen containers are ongoing costs that typically run $150–$300 per procedure depending on the device used.

On the revenue side, image-guided breast biopsy is well-reimbursed. CPT code 19081 (stereotactic-guided breast biopsy, first lesion) reimburses approximately $800–$1,200 depending on payer and facility setting, with additional reimbursement for pathology, clip placement, and post-biopsy imaging. A facility performing 5 biopsies per week at an average collection of $1,000 per procedure generates approximately $260,000 in annual biopsy revenue — enough to achieve full ROI on a refurbished Affirm system within the first year of operation.

Why Buy Your Hologic Affirm System from ARRAD

ARRAD is a trusted source for Hologic breast imaging equipment, including the Affirm prone biopsy system. Facilities choose ARRAD for several reasons:

• Deep Hologic expertise: ARRAD's engineering and sales teams have extensive experience with the full Hologic breast imaging product line, from screening systems to biopsy platforms. This specialization means better pre-sale guidance, faster installations, and more knowledgeable service support.
• New and refurbished options: Whether your budget supports a new Affirm system or a refurbished unit offers the right value, ARRAD provides both pathways with transparent pricing and no hidden costs.
• OEM-quality refurbishment: Every refurbished Affirm system is restored with genuine Hologic parts, updated to current software, and tested against original performance specifications before delivery.
• Comprehensive installation: ARRAD manages the entire installation process including site survey, room preparation coordination, system placement, calibration, and MQSA compliance verification.
• 24/7 technical support: Biopsy systems must be available when patients need them. ARRAD's 24/7 service program ensures rapid response to any technical issue, minimizing procedure cancellations and protecting patient care continuity.

A dedicated prone biopsy system is an investment in diagnostic accuracy, patient safety, and procedural efficiency. The Hologic Affirm remains the benchmark platform in this category, and ARRAD is uniquely positioned to help your facility acquire, install, and maintain it.

To discuss your biopsy system needs, contact ARRAD at info@arrad.net or visit our contact page for a personalized consultation and quote.